CAS: 41731-52-6; Ethyl 2-Chlorothiazole-4-Carboxylate

该化合物是一种有机化合物,其特点是硫化环,这是一个由五人组成的含有硫磺和氮原子的循环结构,由五人组成,含有硫和氮原子.该化合物的特点是一个箱式酸功能组,与乙基组一起被提炼,提高了其在有机溶剂中的溶解性.在硫酸环的2个位置上存在氯原子,有助于其再活性和在各种化学反应中的潜在应用.这种化合物通常具有中度极性,如由于碳本酸运动而呈现的极性,并且由于氯原子的电本性,它们可能参与核分裂性替代反应.这种化合物可用于制药研究,农业化学开发或有机合成的中间体.其具体应用往往取决于现有的功能组和可影响生物活动和化学再活动的整体分子结构.在处理和储存时,应当参考安全数据,因为与所有化学物质一样.

结构式图片

欧盟法规

C&L通报

上下游产品

2-氨基噻唑-4-甲酸乙酯 2-Aminothiazole-4-Carboxylate 5398-36-7

合成工艺路线路线简述

    📜3-乙氧基丙烯酸乙酯置于n-溴代丁二酰亚胺(Nbs),亚硝酸特丁酯,Copper Dichloride体系中,用 四氢呋喃,1,4-二氧六环,水,乙腈 作为反应溶剂,化学反应 2.17H,反应生成 2-氯噻唑-4-甲酸乙酯
    参考文献:Heterocyclic Aminoberbamine Derivatives,The Preparation Process And Use Thereof
    标题:Heterocyclic Aminoberbamine Derivatives,The Preparation Process And Use Thereof
    摘要:本发明涉及一种具有化学式i的新型贝巴明衍生物或其药用盐,以及制备该衍生物的方法,包括所述化合物的药物组合物及其在制造抗肿瘤药物中的应用.

    海关参考信息

    专利信息


    专利号:US-9550757-B2
    优先权日:2010-03-05
    标题:Nuclear transport modulators and uses thereof
    发明人:SHACHAM SHARON; KAUFFMAN MICHAEL; SANDANAYAKA VINCENT P; SHECHTER SHARON
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to the field of nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to new substituted-heterocyclic azole compounds, the synthesis and use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity such as in treating cancer and other neoplastic disorders, inflammatory diseases, disorders of abnormal tissue growth and fibrosis including cardiomyopathy, pulmonary fibrosis, hepatic fibrosis, glomerulonephritis, and other renal disorders, and for the treatment of viral infections (both acute and chronic).

    专利号:US-10988466-B2
    优先权日:2017-03-23
    标题:Heterocyclic derivatives useful as SHP2 inhibitors
    发明人:MA CUNBO; GAO PANLIANG; HU SHAOJING; XU ZILONG; HAN HUIFENG; WU XINPING; KANG DI
    权利人:JACOBIO PHARMACEUTICALS CO LTD
    摘要:This invention relates to certain novel pyrazine derivatives (Formula I) as SHP2 inhibitors which is shown as formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, this invention is directed to fused heterocyclic group derivatives useful as inhibitors of SHP2, methods for producing such compounds and methods for treating a SHP2-mediated disorder.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知